Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Asthma. A role for IVIG therapy?

P Fireman1, G Friday

  • 1University of Pittsburgh, School of Medicine, Children's Hospital of Pittsburgh, PA.

Clinical Reviews in Allergy
|January 1, 1992
PubMed
Summary

Some asthma patients with recurrent infections may have immune deficiencies and benefit from intravenous gamma-globulin (IVIG) therapy. Antibody synthesis assessment is crucial before initiating IVIG for asthma patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Acute stroke trials: Reasons for patient withdrawal.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association·2015
Same author

Transient ischemic attack and risk of stroke recurrence: The Lehigh Valley Recurrent Stroke Study.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association·2007
Same author

Pharmacokinetics and tolerability of a new intravenous immunoglobulin preparation, IGIV-C, 10% (Gamunex, 10%).

Vox sanguinis·2003
Same author

Effect of experimental influenza A infection on systemic immune and inflammatory parameters in allergic and nonallergic adult subjects.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2002
Same author

Urinary histamine metabolite elevations during experimental influenza infection.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2001
Same author

Long-term safety and efficacy of a chlorofluorocarbon-free beclomethasone dipropionate extrafine aerosol.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2001

Area of Science:

  • Immunology
  • Pulmonology
  • Allergy

Background:

  • Asthma is a complex obstructive lung disease characterized by airway inflammation and hyperreactivity.
  • Both respiratory infections and IgE-mediated reactions can trigger asthma pathophysiology.
  • A subset of asthma patients experiences recurrent sinopulmonary infections, potentially indicating an associated immune deficiency syndrome.

Purpose of the Study:

  • To investigate the potential benefits of intravenous gamma-globulin (IVIG) therapy in specific asthma patient cohorts.
  • To evaluate the role of immune deficiencies, including IgG subclass deficiencies, in asthma patients with recurrent infections.
  • To determine appropriate criteria for initiating IVIG therapy in asthma management.

Main Methods:

  • Review of asthma pathophysiology, focusing on infection triggers and immune responses.
  • Analysis of patient subsets with recurrent sinopulmonary infections and potential immune deficiencies.
  • Discussion of treatment strategies, including standard asthma therapies and IVIG.
  • Consideration of diagnostic criteria for IVIG initiation, emphasizing antibody synthesis assessment.

Main Results:

  • Some asthma patients with recurrent infections may present with immune deficiencies, including low or normal IgG with deficient IgA and IgG subclasses.
  • These patients may benefit from IVIG therapy in addition to standard asthma treatments.
  • Serum IgG subclass levels alone are insufficient criteria for initiating IVIG.
  • An inability to synthesize specific antibodies to vaccines/immunogens should be a prerequisite for IVIG therapy.

Conclusions:

  • IVIG therapy can be beneficial for selected asthma patients with immune deficiencies and recurrent infections.
  • Careful patient selection, including assessment of antibody synthesis capacity, is essential before initiating IVIG.
  • Further research may identify additional asthma patient cohorts who could benefit from IVIG.

Related Experiment Videos